|
|
|
|
Дата |
|---|
| 13.08.2026 |
| 12.08.2026 |
| 11.08.2026 |
| 10.08.2026 |
| 07.08.2026 |
| 06.08.2026 |
| 05.08.2026 |
| 04.08.2026 |
| 03.08.2026 |
| 31.07.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
3.91
|
3.99
|
3.875
|
3.87
|
4.075
|
3.995
|
|
3.94
|
828 757.87
|
99.00
|
|
3.875
|
3.925
|
4.06
|
3.875
|
4.06
|
3.925
|
|
3.92
|
312 337.55
|
90.00
|
|
3.99
|
4.01
|
3.985
|
3.855
|
4.095
|
4.03
|
|
3.98
|
860 691.61
|
194.00
|
|
3.945
|
3.985
|
3.745
|
3.69
|
3.99
|
3.99
|
|
3.85
|
1 083 936.14
|
183.00
|
|
3.75
|
3.79
|
3.85
|
3.65
|
3.925
|
3.835
|
|
3.75
|
1 510 141.99
|
230.00
|
|
3.85
|
3.87
|
3.975
|
3.77
|
3.975
|
3.905
|
|
3.85
|
529 076.54
|
160.00
|
|
3.905
|
3.965
|
3.71
|
3.635
|
4.10
|
3.98
|
|
3.76
|
3 859 629.69
|
590.00
|
|
3.59
|
3.63
|
3.705
|
3.575
|
3.72
|
3.65
|
|
3.62
|
372 033.01
|
157.00
|
|
3.635
|
3.65
|
3.815
|
3.60
|
3.815
|
3.65
|
|
3.65
|
371 461.55
|
109.00
|
|
3.655
|
3.71
|
3.775
|
3.625
|
3.775
|
3.70
|
|
3.67
|
438 476.21
|
138.00
|
Senzime AB develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. It operates in Europe and the United States.
